Get started
Work

A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy of Cmvpepvax for Preventing CMV Reactivation/Disease after Matched Related/Unrelated Donor Hematopoietic Cell Transplant

Year: 2021
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2021-153312
Authors: Ryotaro Nakamura, Corinna La Rosa, Dongyun Yang, Joshua A. Hill, Armin Rashidi, Hannah Choe, Qiao Zhou, Chetan Raj Lingaraju, Jeffrey Longmate, Jennifer Drake, Cynthia Slape, Lupe Duarte, Monzr M. Al Malki, Vinod A. Pullarkat, Ahmed Aribi, Thai Cao, Steven Devine, Michael R Verneris, Jeffrey S. Miller, Stephen J Forman, Ibrahim Aldoss, Don J. Diamond
Institutions: City Of Hope National Medical Center, Beckman Research Institute, Fred Hutch Cancer Center, University of Minnesota, The Ohio State University, The Ohio State University Wexner Medical Center, Children's Hospital Colorado, University of Colorado Denver
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: closed
OpenAlex ID: W3211856460
Cites:
Cited by: 3
Related to: 10